In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 3.11 below Guardant Health Inc average.

Within Medical Laboratories industry 13 other companies have achieved higher Quick Ratio than Guardant Health Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 734 to 1087.

Explain Quick Ratio?
How much Cash & cash equivalents GH�s has?
What are GH�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GH Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	42.16 %	29.41 %	43.67 %	20.05 %	18.29 %
Y / Y Cash & cash equivalent Change	67.45 %	57.86 %	-31.12 %	86.68 %	-
Quick Ratio MRQ	3.11	3.77	3.97	2.45	2.64
GH's Total Ranking	# 1087	# 734	# 108	# 908	# 807
Seq. Current Liabilities Change	16.03 %	-3.5 %	27.78 %	-0.63 %	5.62 %
Seq. Cash & cash equivalent Change	-4.47 %	-8.23 %	107.17 %	-7.81 %	-9.94 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Medical Laboratories Industry	# 14
Healthcare Sector	# 397
Overall Market	# 1087

Quick Ratio Statistics
High	Average	Low
22.99	7.86	1.57
(Dec 31 2020)		(Sep 30 2024)

Financial Statements
Guardant Health Inc 's Current Liabilities	$ 339 Millions	Visit GH's Balance sheet
Guardant Health Inc 's Cash & cash equivalent	$ 1,053 Millions	Visit GH's Balance sheet
Source of GH's Sales		Visit GH's Sales by Geography

Cumulative Guardant Health Inc 's Quick Ratio

GH's Quick Ratio for the trailling 12 Months

GH Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	34.22 %	28.11 %	21 %	10.54 %	2.11 %
Y / Y Cash & cash equivalent TTM Growth	16.41 %	27.59 %	51.29 %	146.88 %	45.6 %
Quick Ratio TTM	3.36	3.28	3.1	4.01	3.88
Total Ranking TTM	# 3763	# 2980	# 897	# 1938	# 2992
Seq. Current Liabilities TTM Growth	9.39 %	6.61 %	10.09 %	4.54 %	4.41 %
Seq. Cash & cash equivalent TTM Growth	12.08 %	13 %	-14.86 %	7.96 %	22.85 %

Quick ratio ranking by company, industry and sector >> Back to GH Financial Strength Comparisons >> Go to Compare GH Quick Ratio to its Competitors

On the trailing twelve months basis GH Cash & cash equivalent soared by 67.45 % in Q2 2026 year on year, faster than Current Liabilities, this led to increase in in Guardant Health Inc 's Quick Ratio to 3.36, above GH average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 33 other companies have achieved higher Quick Ratio than Guardant Health Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 2980 to 3763.

Explain Quick Ratio?
How much Cash & cash equivalents GH�s has?
What are GH�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Laboratories Industry	# 34
Healthcare Sector	# 876
Within the Market	# 3763

trailing twelve months Quick Ratio Statistics
High	Average	Low
9.62	3.2	0.62
(Sep 30 2021)		(Dec 31 2024)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Laboratories Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Veracyte Inc	7.76	$ 487.046 Millions	$ 62.736 Millions
Personalis Inc	6.00	$ 278.411 Millions	$ 46.385 Millions
Castle Biosciences Inc	4.72	$ 266.805 Millions	$ 56.509 Millions
Bionexus Gene Lab Corp	4.33	$ 3.522 Millions	$ 0.813 Millions
Caredx Inc	3.99	$ 373.636 Millions	$ 93.698 Millions
Omniab Inc	3.78	$ 51.995 Millions	$ 13.758 Millions
Fulgent Genetics Inc	3.58	$ 257.032 Millions	$ 71.756 Millions
Guardant Health Inc	3.11	$ 1,053.469 Millions	$ 338.962 Millions
Butterfly Network Inc	2.13	$ 124.659 Millions	$ 58.603 Millions
Natera Inc	1.97	$ 1,091.502 Millions	$ 553.200 Millions
Biodesix Inc	1.96	$ 29.996 Millions	$ 15.291 Millions
Sera Prognostics Inc	1.91	$ 46.445 Millions	$ 24.356 Millions
Exagen Inc	1.83	$ 24.588 Millions	$ 13.457 Millions
Radnet Inc	1.11	$ 773.510 Millions	$ 697.822 Millions
Bioaffinity Technologies Inc	0.91	$ 2.430 Millions	$ 2.681 Millions

Date modified: 2026-09-26T07:35:44+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.